Safety concerns : Important risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, hypoglycaemia (when used with insulin or sulfonylureas), and potential worsening of diabetic retinopathy with rapid glycaemic improvement
Pharmacol Ther 113:546593 Moffett RC, Patterson S, Irwin N, Flatt PR (2015) Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes
A prescriber must submit prior authorization and certify the patient is using the medication as part of a lifestyle program focused on diet and exercise
These were reflected in improvements in lipid profiles and glycemic control, with notable reductions in HbA1c and insulin requirements, although the magnitude of benefit varied by specific GLP-1 RA, dosage, and duration of follow-up
Remove the ice, wipe with alcohol, let the alcohol dry, then inject
[DOI] [PubMed] [Google Scholar] 14.Todd J.F., Bloom S.R